BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30551505)

  • 21. Carbon-Ion Irradiation Suppresses Migration and Invasiveness of Human Pancreatic Carcinoma Cells MIAPaCa-2 via Rac1 and RhoA Degradation.
    Fujita M; Imadome K; Shoji Y; Isozaki T; Endo S; Yamada S; Imai T
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):173-80. PubMed ID: 26279033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma.
    Tanabe K; Shinsato Y; Furukawa T; Kita Y; Hatanaka K; Minami K; Kawahara K; Yamamoto M; Baba K; Mori S; Uchikado Y; Maemura K; Tanimoto A; Natsugoe S
    Oncotarget; 2017 Jan; 8(4):6353-6363. PubMed ID: 28031525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antileukemic effect of zerumbone-loaded nanostructured lipid carrier in WEHI-3B cell-induced murine leukemia model.
    Rahman HS; Rasedee A; How CW; Zeenathul NA; Chartrand MS; Yeap SK; Abdul AB; Tan SW; Othman HH; Ajdari Z; Namvar F; Arulselvan P; Fakurazi S; Mehrbod P; Daneshvar N; Begum H
    Int J Nanomedicine; 2015; 10():1649-66. PubMed ID: 25767386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zerumbone modulates CD1d expression and lipid antigen presentation pathway in breast cancer cells.
    Shyanti RK; Sehrawat A; Singh SV; Mishra JPN; Singh RP
    Toxicol In Vitro; 2017 Oct; 44():74-84. PubMed ID: 28633979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zerumbone suppresses EGF-induced CD44 expression through the inhibition of STAT3 in breast cancer cells.
    Kim S; Kil WH; Lee J; Oh SJ; Han J; Jeon M; Jung T; Lee SK; Bae SY; Lee HC; Lee JH; Yi HW; Kim SW; Nam SJ; Lee JE
    Oncol Rep; 2014 Dec; 32(6):2666-72. PubMed ID: 25269647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary zerumbone, a sesquiterpene, ameliorates hepatotoxin-mediated acute and chronic liver injury in mice.
    Kim JW; Yang D; Jeong H; Park IS; Lee MH; Lim CW; Kim B
    Phytother Res; 2019 May; 33(5):1538-1550. PubMed ID: 30868670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated IL-1β expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone.
    Jeon M; Han J; Nam SJ; Lee JE; Kim S
    Chem Biol Interact; 2016 Oct; 258():126-33. PubMed ID: 27567548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zerumbone induces G2/M cell cycle arrest and apoptosis via mitochondrial pathway in Jurkat cell line.
    Rahman HS; Rasedee A; Chartrand MS; Othman HH; Yeap SK; Namvar F
    Nat Prod Commun; 2014 Sep; 9(9):1237-42. PubMed ID: 25918781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mib1 contributes to persistent directional cell migration by regulating the Ctnnd1-Rac1 pathway.
    Mizoguchi T; Ikeda S; Watanabe S; Sugawara M; Itoh M
    Proc Natl Acad Sci U S A; 2017 Oct; 114(44):E9280-E9289. PubMed ID: 29078376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zerumbone Sensitizes the Anti-Cancer Efficacy of Cisplatin in Hepatocellular Carcinoma Cells.
    Jegannathan SD; Arul S; Dayalan H
    Anticancer Agents Med Chem; 2022 Aug; 22(16):2885-2895. PubMed ID: 35331096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway.
    Huang Q; Shen HM; Ong CN
    Cell Mol Life Sci; 2005 May; 62(10):1167-75. PubMed ID: 15928809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.
    Ma S; Lu CC; Yang LY; Wang JJ; Wang BS; Cai HQ; Hao JJ; Xu X; Cai Y; Zhang Y; Wang MR
    J Exp Clin Cancer Res; 2018 Aug; 37(1):183. PubMed ID: 30081903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration.
    Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z
    BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of capsaicin on B16-F10 melanoma cell migration via the phosphatidylinositol 3-kinase/Akt/Rac1 signal pathway.
    Shin DH; Kim OH; Jun HS; Kang MK
    Exp Mol Med; 2008 Oct; 40(5):486-94. PubMed ID: 18985006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Directional Migration in Esophageal Squamous Cell Carcinoma (ESCC) is Epigenetically Regulated by SET Nuclear Oncogene, a Member of the Inhibitor of Histone Acetyltransferase Complex.
    Yuan X; Wang X; Gu B; Ma Y; Liu Y; Sun M; Kong J; Sun W; Wang H; Zhou F; Gao S
    Neoplasia; 2017 Nov; 19(11):868-884. PubMed ID: 28938158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells.
    Lin ML; Lu YC; Chen HY; Lee CC; Chung JG; Chen SS
    Mol Carcinog; 2014 May; 53(5):360-79. PubMed ID: 23192861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation.
    Castillo-Lluva S; Tan CT; Daugaard M; Sorensen PH; Malliri A
    Oncogene; 2013 Mar; 32(13):1735-42. PubMed ID: 22614015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interplay of Rac1 activity, ubiquitination and GDI binding and its consequences for endothelial cell spreading.
    Majolée J; Podieh F; Hordijk PL; Kovačević I
    PLoS One; 2021; 16(7):e0254386. PubMed ID: 34252134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Rac1/WAVE2 Signaling in Mediating the Inhibitory Effects of γ-Tocotrienol on Mammary Cancer Cell Migration and Invasion.
    Algayadh IG; Dronamraju V; Sylvester PW
    Biol Pharm Bull; 2016; 39(12):1974-1982. PubMed ID: 27904039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulated miR-26a promotes proliferation, migration, and invasion
    Yang C; Zheng S; Liu T; Liu Q; Dai F; Zhou J; Chen Y; Sheyhidin I; Lu X
    FASEB J; 2017 May; 31(5):2114-2122. PubMed ID: 28174206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.